Back to Search
RYAN MARAIS, MD
MD
Internal Medicine Physician
NPI: 1922688282IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A192109(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2021
Research & Publications (20)
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF).
PMID 19323560·J Med Chem·2009
7-preclinical
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ring.
PMID 19473026·J Med Chem·2009
8-other
BRAF signaling and targeted therapies in melanoma.
PMID 19464601·Hematol Oncol Clin North Am·2009
6-review
Oncogenic Braf induces melanocyte senescence and melanoma in mice.
PMID 19345328·Cancer Cell·2009
7-preclinical
Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors.
PMID 19376813·Hum Mol Genet·2009
7-preclinical
Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins.
PMID 19114553·Mol Cell Biol·2009
7-preclinical
Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.
PMID 19682280·Pigment Cell Melanoma Res·2009
7-preclinical
Novel inhibitors of the v-raf murine sarcoma viral oncogene homologue B1 (BRAF) based on a 2,6-disubstituted pyrazine scaffold.
PMID 18473434·J Med Chem·2008
8-other
Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.
PMID 18594008·Clin Cancer Res·2008
7-preclinical
Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
PMID 18628967·PLoS One·2008
8-other
BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors.
PMID 18375819·Mol Cancer Ther·2008
3-trial
CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation.
PMID 18922468·Mol Cell·2008
7-preclinical
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
PMID 18348005·Acta Oncol·2008
5-case
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors.
PMID 17332351·Cancer Res·2007
8-other
Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.
PMID 17510425·Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11370 ANDERSON ST STE 3150
LOMA LINDA, CA 92354 - Phone
- (909) 558-2191
Quick Facts
- NPI
- 1922688282
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile